Ventricular Septal Defect: Clinical Trials

2 trials for Ventricular Septal Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Ventricular Septal Defect: new trials by email Literature Review of Ventricular Septal Defect trials Research Report on Ventricular Septal Defect

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
Dexmedetomidine - Transposition of the Great Arteries, Tetralogy of Fallot
Phase 1CompletedCarelon Research1192014-04-022018-03-23
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
Intravenous L-Citrulline, Placebo of Intravenous L-Citrulline - Atrial Septal Defect, Ventricular Septal Defect
Phase 1 / Phase 2CompletedAsklepion Pharmaceuticals, LLC222010-09-012022-07-27

Narrower conditions

Heart Septal Defects, Ventricular (2)  ·  Atrioventricular Septal Defect (1)  ·  Heart Septal Defects, Atrial (1)  ·  Tetralogy of Fallot (1)  ·  Transposition of Great Vessels (1)

Broader conditions

Cardiovascular Abnormalities (2)  ·  Cardiovascular Diseases (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Heart Defects, Congenital (2)  ·  Heart Diseases (2)  ·  Heart Septal Defects (2)

Interventions

Dexmedetomidine (1)

Sponsors

Asklepion Pharmaceuticals, LLC (1)  ·  Carelon Research (1)

Countries

United States (2)

Top investigators

Allan Doctor, MD (1)  ·  Catherine Krawczeski, MD (1)  ·  Frederick E Barr, MD (1)

Results publications

PMID 31623840